GTC is primarily a technology-platform company
I know it. However, I prefer the aproach of Pharming(synergizing the transgenic technology for the production of recombinant proteins for therapeutics and the R&D science).
Although the ATryn market in the U.S., especially, figures to be a nice moneymaker, most of what you are investing in
I´m more interested in the potential of GTCB´s transgenic technology than ATryn. ("moneydriver")
if you do invest
I agree. I do futures trading and I do stock investments (I like to study stocks). Nevertheless, lately I´ve been more a stock trader than a stock value investor(I "love" the concept of the "value investment").
Best Regards from Spain,
J.
